This company has been marked as potentially delisted and may not be actively trading. Longview Acquisition Corp. II (LGV) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrendsBuy This Stock LGV vs. FMS, TMO, ISRG, IDXX, EW, ALC, IQV, DXCM, MTD, and STEShould you be buying Longview Acquisition Corp. II stock or one of its competitors? The main competitors of Longview Acquisition Corp. II include Fresenius Medical Care AG & Co. KGaA (FMS), Thermo Fisher Scientific (TMO), Intuitive Surgical (ISRG), IDEXX Laboratories (IDXX), Edwards Lifesciences (EW), Alcon (ALC), IQVIA (IQV), DexCom (DXCM), Mettler-Toledo International (MTD), and STERIS (STE). These companies are all part of the "med instruments" industry. Longview Acquisition Corp. II vs. Its Competitors Fresenius Medical Care AG & Co. KGaA Thermo Fisher Scientific Intuitive Surgical IDEXX Laboratories Edwards Lifesciences Alcon IQVIA DexCom Mettler-Toledo International STERIS Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) and Longview Acquisition Corp. II (NYSE:LGV) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their valuation, media sentiment, profitability, dividends, analyst recommendations, institutional ownership, earnings and risk. Which has preferable earnings and valuation, FMS or LGV? Fresenius Medical Care AG & Co. KGaA has higher revenue and earnings than Longview Acquisition Corp. II. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioFresenius Medical Care AG & Co. KGaA$20.63BN/A$582.08M$1.2220.47Longview Acquisition Corp. IIN/AN/AN/AN/AN/A Do institutionals & insiders have more ownership in FMS or LGV? 8.4% of Fresenius Medical Care AG & Co. KGaA shares are owned by institutional investors. 26.4% of Longview Acquisition Corp. II shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. Does the media prefer FMS or LGV? In the previous week, Fresenius Medical Care AG & Co. KGaA had 2 more articles in the media than Longview Acquisition Corp. II. MarketBeat recorded 2 mentions for Fresenius Medical Care AG & Co. KGaA and 0 mentions for Longview Acquisition Corp. II. Fresenius Medical Care AG & Co. KGaA's average media sentiment score of 0.84 beat Longview Acquisition Corp. II's score of 0.00 indicating that Fresenius Medical Care AG & Co. KGaA is being referred to more favorably in the media. Company Overall Sentiment Fresenius Medical Care AG & Co. KGaA Positive Longview Acquisition Corp. II Neutral Is FMS or LGV more profitable? Fresenius Medical Care AG & Co. KGaA has a net margin of 3.39% compared to Longview Acquisition Corp. II's net margin of 0.00%. Fresenius Medical Care AG & Co. KGaA's return on equity of 6.75% beat Longview Acquisition Corp. II's return on equity.Company Net Margins Return on Equity Return on Assets Fresenius Medical Care AG & Co. KGaA3.39% 6.75% 3.13% Longview Acquisition Corp. II N/A N/A N/A Do analysts recommend FMS or LGV? Fresenius Medical Care AG & Co. KGaA currently has a consensus price target of $27.80, suggesting a potential upside of 11.33%. Given Fresenius Medical Care AG & Co. KGaA's stronger consensus rating and higher probable upside, research analysts clearly believe Fresenius Medical Care AG & Co. KGaA is more favorable than Longview Acquisition Corp. II.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Fresenius Medical Care AG & Co. KGaA 2 Sell rating(s) 3 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 1.83Longview Acquisition Corp. II 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 SummaryFresenius Medical Care AG & Co. KGaA beats Longview Acquisition Corp. II on 10 of the 11 factors compared between the two stocks. Get Longview Acquisition Corp. II News Delivered to You Automatically Sign up to receive the latest news and ratings for LGV and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding LGV and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LGV vs. The Competition Export to ExcelMetricLongview Acquisition Corp. IIMED INSTRUMENTS IndustryMedical SectorNYSE ExchangeMarket CapN/A$6.88B$5.84B$21.58BDividend YieldN/A1.21%5.68%3.49%P/E RatioN/A26.0175.4129.75Price / SalesN/A191.22515.8186.27Price / CashN/A22.1337.5625.00Price / BookN/A5.0012.154.58Net IncomeN/A$176.38M$3.29B$999.94M Longview Acquisition Corp. II Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LGVLongview Acquisition Corp. IIN/A$10.09flatN/AN/A$0.00N/A0.003High Trading VolumeFMSFresenius Medical Care AG & Co. KGaA3.8281 of 5 stars$24.74+1.8%$27.80+12.4%+18.4%$0.00$20.63B20.281,384News CoverageTMOThermo Fisher Scientific4.9714 of 5 stars$492.20+0.6%$589.38+19.7%-21.5%$186.01B$42.88B28.47125,000Trending NewsAnalyst UpgradeInsider TradeAnalyst RevisionISRGIntuitive Surgical4.9337 of 5 stars$466.86+2.7%$595.95+27.7%-8.2%$167.36B$8.35B65.1115,638News CoveragePositive NewsIDXXIDEXX Laboratories4.2625 of 5 stars$642.99+0.4%$649.44+1.0%+28.1%$51.44B$3.90B53.5411,000News CoveragePositive NewsEWEdwards Lifesciences4.6344 of 5 stars$80.89-0.1%$85.90+6.2%+13.1%$47.52B$5.44B11.6415,800News CoveragePositive NewsAnalyst DowngradeShort Interest ↑ALCAlcon3.7174 of 5 stars$80.11+1.5%$96.06+19.9%-20.5%$39.54B$9.91B37.2625,599IQVIQVIA4.9421 of 5 stars$187.75+2.0%$229.86+22.4%-21.5%$31.91B$15.41B27.1788,000Positive NewsAnalyst UpgradeDXCMDexCom4.9679 of 5 stars$80.51-0.3%$99.89+24.1%+9.7%$31.57B$4.03B55.9110,300Positive NewsMTDMettler-Toledo International4.164 of 5 stars$1,304.65+1.3%$1,311.11+0.5%-9.0%$26.90B$3.87B33.0417,300Positive NewsSTESTERIS4.8715 of 5 stars$245.04+0.7%$273.50+11.6%+2.2%$24.16B$5.46B37.5317,787Positive NewsAnalyst Upgrade Related Companies and Tools Related Companies Fresenius Medical Care AG & Co. KGaA Competitors Thermo Fisher Scientific Competitors Intuitive Surgical Competitors IDEXX Laboratories Competitors Edwards Lifesciences Competitors Alcon Competitors IQVIA Competitors DexCom Competitors Mettler-Toledo International Competitors STERIS Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:LGV) was last updated on 9/14/2025 by MarketBeat.com Staff From Our PartnersWarren Buffett’s #1 AI Stock: Not Mag 7, And NOT on the NasdaqNew Amazon Crisis Could Tank U.S. Stock Market A new panic is halting AI projects at Amazon and could split...Altimetry | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredApple’s falling behindApple just posted record-breaking results, yet its stock barely moved — because in today’s market, investors o...Porter & Company | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | Sponsored6-Figure Target for BTC by 2025The U.S. just announced it's putting GDP data directly onto Bitcoin and Ethereum blockchains. Could this spa...Crypto 101 Media | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredThe $17B signal no one expected…After SpaceX struck a $17 billion deal with EchoStar for a block of radio frequencies, tech analyst Jeff Brown...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Longview Acquisition Corp. II Please log in to your account or sign up in order to add this asset to your watchlist. Share Longview Acquisition Corp. II With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free LGV Stock Alerts